Fulgent Genetics Reports Financial Results for the Third Quarter of 2016
Nov 03, 2016 20:06 pm UTC| Business
Revenue Grows 72% to $5.0 Million Over Third Quarter of Last YearGAAP Net Loss of $1.0 Million; non-GAAP Earnings of $1.1 MillionGross Margin, Adjusted EBITDA and Cash Flow Continue to Grow TEMPLE CITY, Calif., Nov. 03,...
Overstock.com Reports Q3 2016 Results
Nov 03, 2016 20:06 pm UTC| Business
SALT LAKE CITY, Nov. 03, 2016 -- Overstock.com, Inc. (NASDAQ:OSTK) today reported financial results for the quarter ended Sep. 30, 2016. Key Q3 2016 metrics (comparison to Q3 2015): Revenue: $441.6M vs. $391.2M (13%...
Overstock.com Reports Q3 2016 Results
Nov 03, 2016 20:06 pm UTC| Business
SALT LAKE CITY, Nov. 03, 2016 -- Overstock.com, Inc. (NASDAQ:OSTK) today reported financial results for the quarter ended Sep. 30, 2016. Key Q3 2016 metrics (comparison to Q3 2015): Revenue: $441.6M vs. $391.2M (13%...
Bojangles’, Inc. Reports Financial Results for its Third Fiscal Quarter 2016
Nov 03, 2016 20:06 pm UTC| Business
CHARLOTTE, N.C., Nov. 03, 2016 -- Bojangles’, Inc. (Bojangles’) (NASDAQ:BOJA) today announced financial results for the 13-week third fiscal quarter ended September 25, 2016. Bojangles’ also updated its annual guidance...
Bojangles’, Inc. Reports Financial Results for its Third Fiscal Quarter 2016
Nov 03, 2016 20:06 pm UTC| Business
CHARLOTTE, N.C., Nov. 03, 2016 -- Bojangles’, Inc. (Bojangles’) (NASDAQ:BOJA) today announced financial results for the 13-week third fiscal quarter ended September 25, 2016. Bojangles’ also updated its annual guidance...
Aegerion Pharmaceuticals Announces Third Quarter 2016 Financial Results
Nov 03, 2016 20:06 pm UTC| Business
CAMBRIDGE, Mass., Nov. 03, 2016 -- Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR), a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare...
Aegerion Pharmaceuticals Announces Third Quarter 2016 Financial Results
Nov 03, 2016 20:06 pm UTC| Business
CAMBRIDGE, Mass., Nov. 03, 2016 -- Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR), a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare...
noyb Files GDPR Complaints Against TikTok, Grindr, and AppsFlyer Over Alleged Illegal Data Tracking.